Recombinetics, Inc. (RCI)
Transforming Public Health by Engineering Animals for Biomedicine & Food Production .
- Stage Product In Development
- Industry Biotechnology
- Location St Paul, MN, USA
- Currency USD
- Founded August 2008
- Employees 9
- Website recombinetics.com
Company Summary
Recombinetics has developed and acquired a portfolio of proprietary genome engineering technologies it uses to make precise modifications to the genomes of several livestock species. The results are animals with enhanced value for biomedicine and agricultural markets. First products are pigs that exhibit human heart disease. Customers are academic scientists, pharmaceutical and medical device companies, and CROs that want a consistent model.
Team
-
Scott FahrenkrugCEO & Chairman
-
Mark WaltonCMO (Chief Marketing Officer)
-
Perry HackettCSO (Chief Scientific Officer)
-
Justin ZenankoCFO
-
Cliff SteerCMO (Chief Medical Officer)
Advisors
-
General: Cameron Law Office, Business: Larkin & Hoffman, IP: Dardi & Herbert, LLPLawyerUnconfirmedAudits: Olsen Thielen, Taxation & General: Deloitte ToucheAccountantUnconfirmed
Previous Investors
-
Founders, Friends and FamilyUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.